Friday, March 4, 2011
Stem Cell Therapeutics Corp., of Calgary, Alberta, filed a final short-form base shelf prospectus with the securities commissions in British Columbia, Alberta, Manitoba, Ontario and Nova Scotia allowing the company to offer common shares, warrants or units for initial aggregate proceeds of up to $15 million during the next 25 months.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.